Reproductive Genetics has recently added Report Forecast to 2027 to its repository, which comprises of data relating to the market size, share, value, and volume, production processes, revenue generation, the regional analysis of the business vertical, along with the outcomes of analytical tools including, SWOT analysis and Porter’s Five Forces analysis. The report highlights the growth opportunities and challenges that industry players might encounter in the forecast years, along with an elaborate competitive landscape and expansion strategies adopted by the companies functioning in the Keyword Market.The COVID-19 pandemic has affected several sectors of the global market, and the Reproductive Genetics sector is expected to feel the impact of the pandemic. The economic slowdown and dynamic changes in the demands will further affect the growth of the industry. The report covers the impact analysis of the COVID-19 pandemic on the overall Reproductive Genetics industry.
Researchers have taken a holistic approach towards the global market analysis and highlighted the factors that influence the overall growth of the market. The study involves the use of efficient analytical tools like SWOT analysis and Porter’s Five Forces to inspect the strengths, weaknesses, opportunities, and threats associated with the growth of the various market segments. The report provides crucial details, such as the market shares of the key players, which help the reader attain a comprehensive outlook of the Reproductive Genetics market
Key players in the market include Illumina, Inc., Agilent Technologies, Inc., PerkinElmer, Inc., Quest Diagnostics, Thermo Fisher Scientific Inc., Fulgent Genetics, Inc., Centogene AG, Myriad Genetics, Inc., Qiagen N.V., and OPKO Health, Inc.
Get a Free sample of the report : https://www.emergenresearch.com/request-sample/695
In May 2021, Juno Diagnostics, Which is a company focusing on enhancing access to genetic health information, announced that closing of Series A financing round for USD 25 million led by Perceptive Xontogeny Venture (PXV) Fund. The fund will support product development, clinical validation studies, and commercial launch of JunoDx’s product offerings for non-invasive prenatal testing.
Prenatal screening covers a variety of tests doctors recommend for a pregnant patient. Some prenatal screening tests determines the chances a baby may or may not have chromosomal disorders, such as Down Syndrome. Though recommended by doctors, it is non-invasive and optional, and poses no risk to pregnancy as it involves ultrasound and blood work.
Reproductive genetics focus on fertility and reproduction that affect some families in the form of chromosomal and genetic abnormalities that increase risk to biological children, reproductive loss, multiple miscarriages, and family history of genetic abnormalities. Genetic testing for embryos created through IVF is also increasing, and development in genetic testing is making it possible to test for genetic disorders in artificial reproduction, which is driving growth of the market to a significant extent.
Advancements in genomic technologies and implementation of these technologies in clinical medicine has expanded their usage in diagnosis of genetic disorders, carrier screening, and identification of cause of infertility. Some tests are quite expensive, which deters couples from going ahead with the tests, but as there is a decline in cost of sequencing and surge in mixed-ethnicity population, an increasing number of couples/individuals are expected to opt for the procedure and this is expected to support market growth going ahead.
Asia Pacific market revenue is expected to register a rapid CAGR during the forecast period due to increasing demand of genetic testing from India and China. In addition, increased utilization of IVF procedures and advancements in the healthcare sector are major factors driving growth of the market in the region.
Request customization of the report: https://www.emergenresearch.com/request-for-customization/695
Emergen Research has segmented the global reproductive genetics market on the basis of product type, procedure type, technology, application, and region:
Product Type Outlook (Revenue, USD Billion; 2018–2028)
- Laboratory Developed Tests (LDT)
- Reagents and Consumables
Procedure Type Outlook (Revenue, USD Billion; 2018–2028)
- Pre-Natal Screening
- Pre-Implantation Genetic Testing
- Infertility Genetic Testing
- Carrier Screening
Technology Outlook (Revenue, USD Billion; 2018–2028)
- Next-Generation Sequencing (NGS)
- Polymerase chain reaction (PCR)
- In-Situ Hybridization (ISH)
Application Outlook (Revenue, USD Billion; 2018–2028)
- Single Gene Disorder
- Structural Chromosomal Abnormality
Regional Outlook (Revenue, USD Billion; 2018–2028)
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of APAC
- Latin America
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- Rest Of MEA
Key Points of Reproductive Genetics Market:
Extensive coverage of the analysis of the Reproductive Genetics market
Key insights into the regional spread of the industry in key geographies
Radical insights into the vital market trends; both current and emerging trends, and factors influencing the growth of the market
Comprehensive coverage of the impact of the COVID-19 pandemic on the overall growth of the Reproductive Genetics market
Complete data about the key manufacturers and vendors in the Reproductive Genetics market
Read More: https://www.emergenresearch.com/industry-report/reproductive-genetics-market
Neurostimulation Devices Market
Mobile Robot Market
Free Space Optics (FSO) CommunicationTechnologyMarket
Oncolytic Virus TherapiesMarket
Thermoelectric Materials Market
Airborne LiDAR Market
Medical Wearables Market
Medical Wearable Market
Membrane Bioreactor Market
Peristaltic Pumps Market
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
Facebook | LinkdIn | Twitter | Blogs